Targeting Lipids to Improve Outcomes in Your Cath Patients-Undertreatment and Opportunity in Lipid Lowering Therapy for Patients with Coronary and Peripheral Artery Disease

Undertreatment and Opportunity in Lipid Lowering Therapy for Patients with Coronary and Peripheral Artery Disease

Video Transcription

Video Summary

The video transcript discusses strategies for secondary prevention and treatment of atherosclerotic cardiovascular disease (ASCVD) and the importance of proactive management to prevent recurrent events. It highlights the need for aggressive treatment of patients with high atherosclerosis burden and advocates for moving beyond the traditional distinction between primary and secondary prevention. Despite prescribing statins, many patients do not achieve LDL targets due to lack of timely follow-ups and testing. It emphasizes the importance of using non-statin therapies, addressing clinical inertia, and developing localized, tailored approaches to improve patient outcomes. The speaker also references data from studies and trials reaffirming the value of intensive lipid-lowering therapy.

Asset Subtitle

Subhash Banerjee, MD, FSCAI

Keywords

ASCVD prevention

lipid-lowering therapy

non-statin therapies

clinical inertia

atherosclerosis management